false
Catalog
Pediatric Half and Half MAT Waiver Training
Co-Occurring Disorders
Co-Occurring Disorders
Back to course
Pdf Summary
Co-occurring disorders (CODs), which refer to the simultaneous presence of a substance use disorder and another mental health disorder, are common. This module focuses on the challenges of managing patients with psychiatric diagnoses complicating opioid use disorders. It is important for primary care providers to become comfortable with screening for common psychiatric disorders, particularly safety concerns and substance-induced symptoms. A mnemonic called SPASMM (Substances, Psychosis, Anxiety, Safety, Mood, Medical) can be helpful in organizing thoughts during screening. Laboratory testing, including substance use screening, should be done during the initial evaluation. Knowing when to send a patient for an emergency evaluation is crucial. Treatment of co-occurring disorders should be approached simultaneously, and providers should be aware of local availability of mental health services. Three cases are presented in this module: one involving ADHD, one involving anxiety disorders, and one involving depression. In the case of ADHD, medication treatment should continue, but alternatives may need to be considered if parents cannot monitor the medication. For anxiety disorders, treatment should include therapy and potentially medication, while monitoring for substance use. Treatment for depression should be continued even if substance use is identified, and therapy and medication should be used simultaneously. It is important to screen for potential medical causes of depressive symptoms and to educate parents and patients about manic symptoms. Treatment for depression and substance use disorders should continue for 6-12 months after remission of depression symptoms to prevent relapse.
Keywords
Co-occurring disorders
Substance use disorder
Mental health disorder
Opioid use disorders
Primary care providers
Screening
Treatment
ADHD
Anxiety disorders
Depression
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.
Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
PCSS-MOUD
PCSS-MOUD.org
pcss@aaap.org
8-Hour DEA Training Inquiries, email
PCSS-MOUD
.
ORN
opioidresponsenetwork.org
×
Please select your language
1
English